This is a preview of subscription content, log in via an institution to check access.
Notes
2013 US dollars
Reference
Raldow AC, et al. Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ. Journal of Clinical Oncology : 12 Sep 2016. Available from: URL: http:/doi:10.1200/JCO.2016.67.8532
Rights and permissions
About this article
Cite this article
DCIS score not cost effective for guiding radiotherapy. PharmacoEcon Outcomes News 762, 14 (2016). https://doi.org/10.1007/s40274-016-3390-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3390-9